Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohort

Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohort

Abstract Introduction Using the ATN framework, we evaluated the potential of plasma biomarkers to identify abnormal brain amyloid-beta (Aβ) positron emission tomography (PET), tau-PET and neurodegeneration in a socioeconomically disadvantaged population-based cohort. Methods Community-dwelling demen...

Full description

Saved in:

Bibliographic Details
Main Authors:	Menayit Tamrat Dresse, Pamela C. L. Ferreira, Akshay Prasadan, Jihui L. Diaz, Xuemei Zeng, Bruna Bellaver, Guilherme Povala, Victor L. Villemagne, M. Ilyas Kamboh, Ann D. Cohen, Tharick A. Pascoal, Mary Ganguli, Beth E. Snitz, C. Elizabeth Shaaban, Thomas K. Karikari
Format:	Article
Language:	English
Published:	BMC 2025-07-01
Series:	Alzheimer’s Research & Therapy
Subjects:	Amyloid beta Tau pathology Neurodegeneration Neuroimaging ATN framework P-tau217
Online Access:	https://doi.org/10.1186/s13195-025-01803-w
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Detecting amyloid and tau pathology in Parkinson’s disease, 4R-tauopathies and control subjects with plasma pTau217
by: Giulia Musso, et al.
Published: (2025-08-01)

P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
by: Juan Lantero‐Rodriguez, et al.
Published: (2021-11-01)

Early cerebrospinal fluid elevations of pTau-217 in severe traumatic brain injury subjects
by: Hamad Yadikar, et al.
Published: (2025-07-01)

Plasma phosphorylated tau 217 and amyloid‑β 42/40 for amyloid risk in subgroups
by: Heekyoung Kang, et al.
Published: (2025-08-01)

Retinal tau phosphorylation in Alzheimer's disease: A mass spectrometry study
by: Jessica Santiago, et al.
Published: (2025-10-01)

Optimizing timing and cost-effective use of plasma biomarkers in Alzheimer’s disease
by: Hsin-I Chang, et al.
Published: (2025-08-01)

Extracellular tau clearance is governed by its aggregation state and independent of microglial activation by LPS and IFN-γ
by: Andrew Shultz, et al.
Published: (2025-10-01)

Search for lepton-flavor-violating tau decays to ℓα at Belle
by: The BELLE collaboration, et al.
Published: (2025-08-01)

Elevated 24-hydroxycholesterol levels counteract okadaic acid-induced tau hyperphosphorylation and neuronal morphology impairment
by: Serena Giannelli, et al.
Published: (2025-10-01)

Non-mutated human tau stimulates Alzheimer’s disease-relevant neurodegeneration in a microglia-dependent manner
by: Ethan R. Roy, et al.
Published: (2025-07-01)

Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
by: Rik Ossenkoppele, et al.
Published: (2021-07-01)

Trees vs neural networks for enhancing tau lepton real-time selection in proton-proton collisions
by: Maayan Yaari, et al.
Published: (2025-07-01)

Ante-mortem cognitive trajectories associated with Aβ and tau biomarker profiles in older adults with cerebrovascular disease: a longitudinal cohort study
by: Emily Rosenich, et al.
Published: (2025-07-01)

Concentration‐Based Analysis of Metal‐Induced Tau Fibrillar versus non‐fibrillar Aggregation: Implications for Neurotoxicity in Alzheimer's Disease
by: Mahzad Irandoust, et al.
Published: (2025-08-01)

Strategies for Treating Alzheimer’s: Current Approaches and Future Perspectives
by: Adriana Skuba, et al.
Published: (2025-05-01)

RA-PR058, a novel ramalin derivative, reduces BACE1 expression and phosphorylation of tau in Alzheimer’s disease mouse models
by: Yongeun Cho, et al.
Published: (2025-12-01)

Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort
by: Divya Bali, et al.
Published: (2025-06-01)

Tau aggregation induces cell death in iPSC-derived neurons
by: Hirokazu Tanabe, et al.
Published: (2025-01-01)

Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
by: Michael Ewers, et al.
Published: (2020-08-01)

18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
by: Niklas Mattsson, et al.
Published: (2017-07-01)

Search for lepton-flavor-violating $${\tau }^{-}\to {{\ell}}^{-}{K}_{s}^{0}$$ decays at Belle and Belle II
by: The Belle and Belle II collaborations, et al.
Published: (2025-08-01)

Pathological α-synuclein elicits granulovacuolar degeneration independent of tau
by: Dylan J. Dues, et al.
Published: (2025-06-01)

Enhancing protein O-GlcNAcylation in down syndrome mice mitigates memory dysfunctions through the rescue of mitochondrial bioenergetics, stress responses and pathological markers
by: Chiara Lanzillotta, et al.
Published: (2025-09-01)

Sleep reduces CSF concentrations of beta-amyloid and tau: a randomized crossover study in healthy adults
by: Tim Lyckenvik, et al.
Published: (2025-08-01)

The Advancements of Marine Natural Products in the Treatment of Alzheimer’s Disease: A Study Based on Cell and Animal Experiments
by: Chunbo Jia, et al.
Published: (2025-02-01)

An improved immunoassay detects Aβ oligomers in human biofluids: their CSF levels rise with tau and phosphotau levels
by: Ting Yang, et al.
Published: (2025-07-01)

Modulation of neuronal α1-adrenergic receptor reduces tauopathy and neuroinflammation by inhibiting the STING/NF-κB/NLRP3 signaling pathway in Alzheimer’s disease mice
by: Bo Li, et al.
Published: (2025-07-01)

A single-snapshot inverse solver for two-species graph model of tau pathology spreading in human Alzheimer’s disease
by: Zheyu Wen, et al.
Published: (2025-07-01)

A comprehensive review on novel opportunities for Alzheimer therapy by targeting BIN1
by: Trina Saha, et al.
Published: (2025-08-01)

Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads
by: Gemma Salvadó, et al.
Published: (2023-03-01)

Temporal Muscle Thickness as a New Biomarker: Its Association With Alzheimer Pathology and Cognitive Impairment in Chinese Adults
by: Yunxia Zhu, et al.
Published: (2025-08-01)

Prospecting salivary tau as a diagnostic for Alzheimer’s type dementia
by: Gustavo Alves Andrade dos Santos, et al.
Published: (2025-04-01)

Vascular risk is not associated with PET measures of Alzheimer's disease neuropathology among cognitively normal older adults
by: Murat Bilgel, et al.
Published: (2021-12-01)

New Possibilities for Evaluating Markers of Alzheimer's Disease in Blood Serum
by: S. V. Vorobev, et al.
Published: (2025-06-01)

Distinct regulation of Tau Monomer and aggregate uptake and intracellular accumulation in human neurons
by: Amir T. Marvian, et al.
Published: (2024-12-01)

Fate and propagation of endogenously formed Tau aggregates in neuronal cells
by: Patricia Chastagner, et al.
Published: (2020-11-01)

Tauopathy and cognitive impairment in experimental diabetes mellitus
by: Mariia V. Matveeva, et al.
Published: (2017-08-01)

Advancement in modeling of Alzheimer’s disease: a comprehensive review of preclinical screening platforms
by: Souvik Adak, et al.
Published: (2025-08-01)

Successful stimulation of myocardial ganglionic plexi by Tau-20 in the absence of cardiac damage
by: Shengzhe Li, et al.
Published: (2025-03-01)

Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer’s disease
by: Abdolhossein Zare, et al.
Published: (2025-07-01)